Who has invested in Exagen?

H.I.G. BioHealth Partners, Tullis Health Funds, Sun Mountain, Hunt Holdings are named among the investors backing Exagen.

Exagen Funding: $23M Raised, Series B (2019)

Exagen funding overview

Exagen is based in San Diego, California. Exagen has raised $23M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in July 2019. The round record for Exagen runs through 2019; nothing later has been disclosed. Investors on record include H.I.G. BioHealth Partners, Tullis Health Funds, Sun Mountain, Hunt Holdings. 4 distinct backers are named across the disclosed rounds.

Exagen at a glance

Total raised: $23M
Latest round: Series B
Latest round date: July 2019
Headquarters: San Diego, California
Notable investors: H.I.G. BioHealth Partners, Tullis Health Funds, Sun Mountain, Hunt Holdings

Frequently asked about Exagen funding

How much has Exagen raised?: Exagen has raised $23M in total disclosed funding across the rounds on record.
Who has invested in Exagen?: H.I.G. BioHealth Partners, Tullis Health Funds, Sun Mountain, Hunt Holdings are named among the investors backing Exagen.
What was the latest Exagen funding round?: The most recent disclosed round is a Series B, announced in July 2019.
Where is Exagen based?: Exagen is based in San Diego, California.
When did Exagen last raise?: The last disclosed Exagen round closed in July 2019 at Series B.

Totals shown for Exagen aggregate every disclosed round on file. To see how that compares, browse the companies in San Diego and the investors behind them below.

Exagen Funding: $23M Raised, Series B (2019)

Exagen funding overview

Exagen at a glance

Frequently asked about Exagen funding

Companies related to Exagen (20)

Browse related funding lists (5)